Published in Medical Letter on the CDC and FDA, July 1st, 2007
The new report Treatment Algorithms in Type 2 Diabetes finds that Avandia and Actos are prescribed to 32.2% of second-line patients, according to patient-level claims...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA